Abstract
Background Choline is an essential micronutrient crucial for fetal neurodevelopment. Numerous rodent studies reveal that maternal prenatal choline deficiency produces lifelong offspring cognitive deficits and that maternal choline supplementation produces lifelong improvements to offspring cognition. Few studies have evaluated this question in humans, and with mixed results.
Nonetheless, the available data raise concerns about the low choline intakes of pregnant women and highlight the need for knowledge on the functional consequences of various choline intakes during pregnancy. To address this, the present study evaluates the cognitive and affective functioning of adolescents born to women who participated in a randomized controlled trial of two levels of choline intake during pregnancy.
Methods In a double-blind controlled choline feeding trial, (N = 26) third-trimester pregnant women were randomly assigned to daily choline consumption at 480 mg/d or 930 mg/d. In this 14-year follow-up, the offspring (n = 21) of these women will complete cognitive tests proctored over conferencing software. We will also assess facets of mental health using the Achenbach System of Empirically Based Assessment. These assessments will test the hypothesis that third trimester maternal choline intake exerts lasting effects on offspring attention, memory, executive function, and mental health.
Significance and Impact We hypothesize that adolescent offspring born to women in the 930 mg/d group will perform better in domains of memory, attention, executive function, and mental health than offspring of the 480 mg/d group. This study is unique because total maternal choline intake is precisely known, and the offspring are followed into adolescence, a time when group differences are indicative of lifelong effects of the prenatal intervention. The findings will provide important new information concerning the lasting functional consequences of maternal choline intake during pregnancy for offspring neurobehavioral health, thereby informing dietary recommendations and supplementation policies for pregnant women.
Trial registration ClinicalTrials.gov: NCT05859126
Competing Interest Statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Canfield serves as a consultant for Balchem Corporation, though the study and its funding predates this arrangement. Balchem corporation had no role in the study design, interpretation of data, or writing of manuscripts. No other authors have competing interests.
Clinical Trial
https://clinicaltrials.gov/study/NCT05859126
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cornell University IRB approved this study (IRB0149390) An amendment was approved on 09/16/2024. Written informed consent was obtained from parents of the adolescent participants and written assent was provided by the adolescent participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No datasets have yet been generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
